The PARAMOUNT Trial: A Phase III Randomized Study of Maintenance Pemetrexed Versus Placebo Immediately Following Induction First-line Treatment with Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small Cell Lung Cancer

Publisher: Bentham Science Publishers

E-ISSN: 1876-1038|8|1|23-28

ISSN: 1574-8871

Source: Reviews on Recent Clinical Trials, Vol.8, Iss.1, 2013-01, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content